The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.530
-0.260 (-14.53%)
At close: Nov 15, 2024, 4:00 PM
1.510
-0.020 (-1.31%)
After-hours: Nov 15, 2024, 7:48 PM EST
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for SKIN stock have an average target of 2.38, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 55.56% from the current stock price of 1.53.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SKIN stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 6 | 4 |
| Sell | 3 | 3 | 3 | 3 | 3 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.25 → $1.75 | Hold | Maintains | $1.25 → $1.75 | +14.38% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -18.30% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | -34.64% | Aug 9, 2024 |
| Stifel | Stifel | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +30.72% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Sell Maintains $2.5 → $1.5 | Sell | Maintains | $2.5 → $1.5 | -1.96% | Jul 11, 2024 |
Financial Forecast
Revenue This Year
338.20M
from 397.99M
Decreased by -15.02%
Revenue Next Year
365.98M
from 338.20M
Increased by 8.21%
EPS This Year
-0.20
from -0.76
EPS Next Year
-0.16
from -0.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 354.6M | 421.0M | 449.4M | ||
| Avg | 338.2M | 366.0M | 415.5M | ||
| Low | 313.4M | 303.6M | 360.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -10.9% | 24.5% | 22.8% | ||
| Avg | -15.0% | 8.2% | 13.5% | ||
| Low | -21.3% | -10.2% | -1.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.14 | 0.26 | 0.38 |
| Avg | -0.20 | -0.16 | -0.04 |
| Low | -0.27 | -0.34 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.